Vivus brings manufacture in-house to save money:
This article was originally published in Clinica
Vivus, the erectile dysfunction device company based in Mountain View, California, has ceased using a contract manufacturer and says that it can produce sufficient product for the market at present at its new factory. Vivus is currently considering a possible sale of the company, which has been severely damaged by Pfizer's launch of its Viagra pharmaceutical alternative (see Clinica No 823, p 7).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.